The Challenge of Evidence Generation
In the Tuesday morning WFH session on global surveillance and collaboration, Glenn Pierce, explores the challenges of evidence generation.
Essential Medicines List, Orphan Drugs, and Paid Plasma
In the Tuesday morning WFH session on global surveillance and collaboration, Brian O’Mahony, provides his vision for the role of the WFH in ensuring adequate access to a safe supply of hemophilia treatment.
Blood Safety and Donor Deferrals: The history and ongoing risk evaluation
In the Tuesday morning WFH session on global surveillance and collaboration, David Page, discusses donor deferrals, issues of blood safety and the role of the WFH.
Medical Plenary: Hemophilia treatment in 2030
In the Tuesday morning medical plenary, Erik Berntorp describes his vision of hemophilia treatment and medical advances in 2030.
Ageing with hemophilia: Dental issues
In the Thursday morning session entitled Ageing with Hemophilia: Issues and Challenges Through Different Life Stages, Andrew Brewer presents his experiences working as a dentist with people with hemophilia of all ages. This talk was part of the Panel Discussion session: Ageing with Hemophilia: Issues & challenges through different life stages. See below for other […]
Porcine Factor VIII
In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.
Report on the Annual Global Survey 2015
Compiled annually, the Annual Global Survey (AGS) provides demographic and other data on people with hemophilia, von Willebrand disease, other rare factor deficiencies, and inherited platelet disorders throughout the world.
WFH Webinar: Treatment Options for Hemophilia in the Developing World
On December 16, 2016, the WFH in collaboration with the ISTH, recorded a live interactive webinar on the challenges and opportunities of treatment options for hemophilia in the developing world, now available for viewing here. Introduced by Marijke van den Berg, Rolf Ljung opened with a summary of the lessons learned from decades of experience […]
ePosters of the XXXII International Congress of the World Federation of Hemophilia
This interactive carousel features over 500 posters presented at the WFH 2016 World Congress, which can be searched by title, author, poster number, or topic. Via the Options tab on the right, viewers may download, print, or email posters; email poster authors directly; or participate in an online discussion. Presentation slides can also be viewed […]
Abstracts of the XXXII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2016 World Congress Orlando (July 2016, Vol 22, Issue Supplement S4 Pages 1–152) features abstracts of many of the posters presented at the Congress, including Late-Breaking Abstracts and those selected for presentation as Free Papers.
Pathogenic or Not? Classification of genetic variants in haemostasis
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Anne Goodeve explains the classification of genetic variants in haemostasis.
State of the Art of the XXXII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2016 World Congress Orlando (Vol 22, Issue Supplement S5 Pages 1–95) features reviews of the state of the art of each of the topics of the medical plenaries, medical sessions, and laboratory science sessions at the Congress, written by featured speakers.